These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15380535

  • 1. The role of nasal tolerance in a model of IgA nephropathy induced in mice by Sendai virus.
    Amore A, Coppo R, Nedrud JG, Sigmund N, Lamm ME, Emancipator SN.
    Clin Immunol; 2004 Oct; 113(1):101-8. PubMed ID: 15380535
    [Abstract] [Full Text] [Related]

  • 2. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.
    Jessen RH, Emancipator SN, Jacobs GH, Nedrud JG.
    Lab Invest; 1992 Sep; 67(3):379-86. PubMed ID: 1328763
    [Abstract] [Full Text] [Related]

  • 3. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN, Ovary Z, Lamm ME.
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [Abstract] [Full Text] [Related]

  • 4. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization.
    Gesualdo L, Lamm ME, Emancipator SN.
    J Immunol; 1990 Dec 01; 145(11):3684-91. PubMed ID: 1700991
    [Abstract] [Full Text] [Related]

  • 5. Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions.
    Sha Z, Kang SM, Compans RW.
    Virology; 2005 Jan 20; 331(2):387-95. PubMed ID: 15629781
    [Abstract] [Full Text] [Related]

  • 6. A case of IgA nephropathy associated with marked hematuria after upper respiratory tract infections.
    Miura M, Tomino Y, Endoh M, Suga T, Kaneshige H, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1982 Sep 20; 7(5):583-7. PubMed ID: 6222518
    [Abstract] [Full Text] [Related]

  • 7. T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.
    Chintalacharuvu SR, Yamashita M, Bagheri N, Blanchard TG, Nedrud JG, Lamm ME, Tomino Y, Emancipator SN.
    Clin Exp Immunol; 2008 Sep 20; 153(3):456-62. PubMed ID: 18637102
    [Abstract] [Full Text] [Related]

  • 8. Double immunofluorescence studies on IgA-associated immune-complexes in glomerular deposits in patients with IgA nephropathy.
    Tomino Y, Nomoto Y, Endoh M, Sakai H, Arimori S.
    Tokai J Exp Clin Med; 1980 Apr 20; 5(2):147-9. PubMed ID: 6998050
    [Abstract] [Full Text] [Related]

  • 9. Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses.
    Takao SI, Kiyotani K, Sakaguchi T, Fujii Y, Seno M, Yoshida T.
    J Virol; 1997 Jan 20; 71(1):832-8. PubMed ID: 8985426
    [Abstract] [Full Text] [Related]

  • 10. IgA nephropathy: lessons from an animal model, the ddY mouse.
    Tomino Y.
    J Nephrol; 2008 Jan 20; 21(4):463-7. PubMed ID: 18651534
    [Abstract] [Full Text] [Related]

  • 11. Immune complexes in IgA nephropathy (Berger's disease).
    Stachura I.
    Pathol Annu; 1983 Jan 20; 18 Pt 2():295-314. PubMed ID: 6232491
    [No Abstract] [Full Text] [Related]

  • 12. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
    Yao XY, Yuan MM, Li DJ.
    Methods; 2006 Feb 20; 38(2):124-32. PubMed ID: 16414267
    [Abstract] [Full Text] [Related]

  • 13. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
    Valosky J, Hishiki H, Zaoutis TE, Coffin SE.
    Clin Diagn Lab Immunol; 2005 Jan 20; 12(1):171-9. PubMed ID: 15643003
    [Abstract] [Full Text] [Related]

  • 14. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
    Yin GR, Meng XL, Ma GY, Ma XM.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug 20; 25(4):290-4. PubMed ID: 18038798
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.
    Microbiol Immunol; 2008 Feb 20; 52(2):55-63. PubMed ID: 18380802
    [Abstract] [Full Text] [Related]

  • 16. Studies on the immune response and pathogenesis of Sendai virus infection of mice. III. The effects of cyclophosphamide.
    Blandford G.
    Immunology; 1975 May 20; 28(5):871-83. PubMed ID: 166035
    [Abstract] [Full Text] [Related]

  • 17. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J, Schmitz N, Hinton HJ, Schwarz K, Jegerlehner A, Bachmann MF.
    Eur J Immunol; 2008 Jan 20; 38(1):114-26. PubMed ID: 18081037
    [Abstract] [Full Text] [Related]

  • 18. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 19. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL, Bouma A, Weerdmeester K, Stegeman JA, Dekker A.
    Vaccine; 2007 Jan 22; 25(6):1043-54. PubMed ID: 17157418
    [Abstract] [Full Text] [Related]

  • 20. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E, Ryzhikov E, Poryvaev V, Bulychev L, Karpyshev N, Maksyutov A, Ryzhikov AB.
    Int J Med Microbiol; 2006 May 22; 296 Suppl 40():195-201. PubMed ID: 16545605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.